Accuracy of individual rapid tests for serodiagnosis of gambiense sleeping sickness in West Africa.

Accuracy of individual rapid tests for serodiagnosis of gambiense sleeping sickness in West Africa.

BACKGROUND:Individual rapid tests for serodiagnosis (RDT) of human African trypanosomiasis (HAT) are particularly suited for passive screening and surveillance. However, so far, no large scale evaluation of RDTs has been performed for diagnosis of Trypanosoma brucei gambiense HAT in West Africa. The...

Full description

Bibliographic Details
Main Authors:	Vincent Jamonneau, Oumou Camara, Hamidou Ilboudo, Moana Peylhard, Mathurin Koffi, Hassane Sakande, Louis N'Dri, Djénéba Sanou, Emilie Dama, Mamadou Camara, Veerle Lejon
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-02-01
Series:	PLoS Neglected Tropical Diseases
Online Access:	http://europepmc.org/articles/PMC4314185?pdf=render

Similar Items

Immune trypanolysis test as a promising bioassay to monitor the elimination of gambiense human African trypanosomiasis
by: Dama Emilie, et al.
Published: (2019-01-01)

The challenge of serodiagnosis of sleeping sickness in the context of elimination
by: Vincent Jamonneau, et al.
Published: (2014-06-01)

Unravelling human trypanotolerance: IL8 is associated with infection control whereas IL10 and TNFα are associated with subsequent disease development.
by: Hamidou Ilboudo, et al.
Published: (2014-11-01)

Revisiting the immune trypanolysis test to optimise epidemiological surveillance and control of sleeping sickness in West Africa.
by: Vincent Jamonneau, et al.
Published: (2010-01-01)

Untreated human infections by Trypanosoma brucei gambiense are not 100% fatal.
by: Vincent Jamonneau, et al.
Published: (2012-01-01)

Correction: The miRNA and mRNA Signatures of Peripheral Blood Cells in Humans Infected with Trypanosoma brucei gambiense
by: Smiths Lueong, et al.
Published: (2013-01-01)

The miRNA and mRNA Signatures of Peripheral Blood Cells in Humans Infected with Trypanosoma brucei gambiense.
by: Smiths Lueong, et al.
Published: (2013-01-01)

Sensitivity and specificity of HAT Sero-K-SeT, a rapid diagnostic test for serodiagnosis of sleeping sickness caused by Trypanosoma brucei gambiense: a case-control study
by: Dr. Philippe Büscher, PhD, et al.
Published: (2014-06-01)

Reducing Human-Tsetse Contact Significantly Enhances the Efficacy of Sleeping Sickness Active Screening Campaigns: A Promising Result in the Context of Elimination.
by: Fabrice Courtin, et al.
Published: (2015-01-01)

Performance of parasitological and molecular techniques for the diagnosis and surveillance of gambiense sleeping sickness.
by: Dieudonné Mumba Ngoyi, et al.
Published: (2014-06-01)

Sleeping sickness in the historical focus of forested Guinea: update using a geographically based method
by: Courtin Fabrice, et al.
Published: (2019-01-01)

The natural progression of Gambiense sleeping sickness: what is the evidence?
by: Francesco Checchi, et al.
Published: (2008-01-01)

Description of the first sleeping sickness case diagnosed in Burkina Faso since two decades.
by: Emilie Dama, et al.
Published: (2018-08-01)

Cerebrospinal fluid neopterin as marker of the meningo-encephalitic stage of Trypanosoma brucei gambiense sleeping sickness.
by: Natalia Tiberti, et al.
Published: (2012-01-01)

Impact of the Ebola outbreak on Trypanosoma brucei gambiense infection medical activities in coastal Guinea, 2014-2015: A retrospective analysis from the Guinean national Human African Trypanosomiasis control program.
by: Mariame Camara, et al.
Published: (2017-11-01)

Diagnostic accuracy of PCR in gambiense sleeping sickness diagnosis, staging and post-treatment follow-up: a 2-year longitudinal study.
by: Stijn Deborggraeve, et al.
Published: (2011-02-01)

Estimates of the duration of the early and late stage of gambiense sleeping sickness
by: Chandramohan Daniel, et al.
Published: (2008-02-01)

Analysis of a model of gambiense sleeping sickness in humans and cattle
by: A. M. Ndondo, et al.
Published: (2016-01-01)

Specificity of malaria rapid diagnostic tests is affected by <it>Trypanosoma brucei gambiense</it> sleeping sickness
by: Gillet Philippe, et al.
Published: (2012-10-01)

Neopterin is a cerebrospinal fluid marker for treatment outcome evaluation in patients affected by Trypanosoma brucei gambiense sleeping sickness.
by: Natalia Tiberti, et al.
Published: (2013-01-01)

TLTF in cerebrospinal fluid for detection and staging of T. b. gambiense infection.
by: Maha-Hamadien Abdulla, et al.
Published: (2013-01-01)

A targeted door-to-door strategy for sleeping sickness detection in low-prevalence settings in Côte d’Ivoire
by: Koffi Mathurin, et al.
Published: (2016-01-01)

Trypa-NO! contributes to the elimination of gambiense human African trypanosomiasis by combining tsetse control with "screen, diagnose and treat" using innovative tools and strategies.
by: Joseph Mathu Ndung'u, et al.
Published: (2020-11-01)

The study of trypanosome species circulating in domestic animals in two human African trypanosomiasis foci of Côte d'Ivoire identifies pigs and cattle as potential reservoirs of Trypanosoma brucei gambiense.
by: Martial Kassi N'Djetchi, et al.
Published: (2017-10-01)

Identification of peptide mimotopes of Trypanosoma brucei gambiense variant surface glycoproteins.
by: Liesbeth Carolien Van Nieuwenhove, et al.
Published: (2011-06-01)

Epidemiology of sleeping sickness in Boffa (Guinea): where are the trypanosomes?
by: Moise Saa Kagbadouno, et al.
Published: (2012-01-01)

Candidate gene polymorphisms study between human African trypanosomiasis clinical phenotypes in Guinea.
by: Justin Windingoudi Kaboré, et al.
Published: (2017-08-01)

Domestic animals as potential reservoir hosts of Trypanosoma brucei gambiense in sleeping sickness foci in Cameroon
by: Njiokou F., et al.
Published: (2010-03-01)

NECT is next: implementing the new drug combination therapy for Trypanosoma brucei gambiense sleeping sickness.
by: Oliver Yun, et al.
Published: (2010-05-01)

Recombinant antigens expressed in Pichia pastoris for the diagnosis of sleeping sickness caused by Trypanosoma brucei gambiense.
by: Stijn Rogé, et al.
Published: (2014-07-01)

Accelerating elimination of sleeping sickness from the Guinean littoral through enhanced screening in the post-Ebola context: A retrospective analysis.
by: Oumou Camara, et al.
Published: (2021-02-01)

Identification of mimotopes with diagnostic potential for Trypanosoma brucei gambiense variant surface glycoproteins using human antibody fractions.
by: Liesbeth Van Nieuwenhove, et al.
Published: (2012-01-01)

In-hospital safety in field conditions of nifurtimox eflornithine combination therapy (NECT) for T. b. gambiense sleeping sickness.
by: Caecilia Schmid, et al.
Published: (2012-01-01)

Silent Human Trypanosoma brucei gambiense Infections around the Old Gboko Sleeping Sickness Focus in Nigeria
by: Karshima Solomon Ngutor, et al.
Published: (2016-01-01)

Isolation of Trypanosoma brucei gambiense from cured and relapsed sleeping sickness patients and adaptation to laboratory mice.
by: Patient Pati Pyana, et al.
Published: (2011-01-01)

Neopterin and CXCL-13 in Diagnosis and Follow-Up of Trypanosoma brucei gambiense Sleeping Sickness: Lessons from the Field in Angola
by: Julien Bonnet, et al.
Published: (2019-01-01)

A comparison of phenotypic traits related to trypanotolerance in five west african cattle breeds highlights the value of shorthorn taurine breeds.
by: David Berthier, et al.
Published: (2015-01-01)

Gambiense human african trypanosomiasis and immunological memory: effect on phenotypic lymphocyte profiles and humoral immunity.
by: Veerle Lejon, et al.
Published: (2014-03-01)

CARBOHYDRATE TRANSPORT IN TRYPANOSOMA GAMBIENSE
by: SOUTHWORTH, GEORGE CLARK
Published: (2007)

African Trypanosomiasis Gambiense, Italy
by: Zeno Bisoffi, et al.
Published: (2005-11-01)